Comparisons of I-123 diagnostic and I-131 post-treatment scans for detecting residual thyroid tissue and metastases of differentiated thyroid cancer

Annals of Nuclear Medicine

Volumn 23, Issue 9, 2009, Pages 777-782

  Iwano, Shingo ^a   Kato, Katsuhiko ^b   Nihashi, Takashi ^a   Ito, Shinji ^c   Tachi, Yasushi ^d   Naganawa, Shinji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c TOYOTA MEMORIAL HOSPITAL   (Japan)

^d KOMAKI CITY HOSPITAL   (Japan)

Author keywords

I 123; I 131; Radioiodine treatment; Thyroid cancer; Whole body scan

Indexed keywords

IODINE 123; IODINE 131; THYROGLOBULIN; THYROTROPIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CERVICAL LYMPH NODE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLICULAR CARCINOMA; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CANCER; THYROID GLAND; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; RADIATION DOSAGE; THYROID GLAND; THYROID NEOPLASMS; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 73449107117     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0303-z     Document Type: Article

References (22)

1. SD Sarkar TP Kalapparambath CJ Palestro 2002 Comparison of (123)I and (131)I for whole-body imaging in thyroid cancer J Nucl Med 43 632 634 11994526
2. EB Silberstein 2007 Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma J Nucl Med 48 1043 1046 10.2967/jnumed.107.040311 1:CAS:528: DC%2BD2sXhtVertL7I 17574976 (Pubitemid 47052640)
3. SJ Mandel LK Shankar F Benard A Yamamoto A Alavi 2001 Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer Clin Nucl Med 26 6 9 10.1097/00003072- 200101000-00002 1:STN:280:DC%2BD3MzgtVSksQ%3D%3D 11139058 (Pubitemid 32003174)
4. Y Tachi S Iwano K Kato M Tadokoro S Naganawa 2008 Diagnostic whole-body scanning before radioiodine therapy for pulmonary metastases of differentiated thyroid cancer: predictive value and recommendations Clin Nucl Med 33 845 851 10.1097/RLU.0b013e31818bf146 19033784
5. HM Park YH Park XH Zhou 1997 Detection of thyroid remnant/metastasis without stunning: an ongoing dilemma Thyroid 7 277 280 10.1089/thy.1997.7.277 1:STN:280:DyaK2s3nvFWqsA%3D%3D 9133700
6. HM Park OW Perkins JW Edmondson RB Schnute A Manatunga 1994 Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131 Thyroid 4 49 54 10.1089/thy.1994.4.49 1:STN:280:DyaK2czjtF2qtg%3D%3D 8054861
7. W Yaakob L Gordon KM Spicer SJ Nitke 1999 The usefulness of iodine-123 whole-body scans in evaluating thyroid carcinoma and metastases J Nucl Med Technol 27 279 281 1:STN:280:DC%2BD3c7htVCltw%3D%3D 10646545
8. A Siddiqi RR Foley KE Britton A Sibtain PN Plowman AB Grossman, et al. 2001 The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning Clin Endocrinol (Oxf) 55 515 521 10.1046/j.1365-2265.2001.01376.x 1:STN:280:DC%2BD3MrntFSksg%3D%3D (Pubitemid 32955490)
9. AS Alzahrani S Bakheet M Al Mandil A Al-Hajjaj A Almahfouz A Al Haj 2001 123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning J Clin Endocrinol Metab 86 5294 5300 10.1210/jc.86.11.5294 1:CAS:528:DC%2BD3MXos1KqsLk%3D 11701695 (Pubitemid 33070250)
10. SK Gerard RR Cavalieri 2002 I-123 diagnostic thyroid tumor whole-body scanning with imaging at 6, 24, and 48 hours Clin Nucl Med 27 1 8 10.1097/00003072-200201000-00001 11805475 (Pubitemid 34016895)
11. N Ali C Sebastian RR Foley I Murray AL Canizales PJ Jenkins, et al. 2006 The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy Nucl Med Commun 27 165 169 10.1097/01.mnm.0000194397. 20067.b6 16404230 (Pubitemid 44391826)
12. JB Cohen JE Kalinyak IR McDougall 2004 Clinical implications of the differences between diagnostic I-123 and post-therapy 131I scans Nucl Med Commun 25 129 134 10.1097/00006231-200402000-00006 15154700 (Pubitemid 38315414)
13. KP Donahue NP Shah SL Lee ME Oates 2008 Initial staging of differentiated thyroid carcinoma: continued utility of posttherapy 131I whole-body scintigraphy Radiology 246 887 894 10.1148/radiol.2463061328 18309016
14. LK Shankar AJ Yamamoto A Alavi SJ Mandel 2002 Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer J Nucl Med 43 72 76 11801706
15. M Urhan S Dadparvar A Mavi M Houseni W Chamroonrat A Alavi, et al. 2007 Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement Eur J Nucl Med Mol Imaging 34 1012 1017 10.1007/s00259-006-0341-x 1:CAS:528:DC%2BD2sXmtl2jt7k%3D 17256140 (Pubitemid 46919552)
16. C Durante N Haddy E Baudin S Leboulleux D Hartl JP Travagli, et al. 2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab 91 2892 2899 10.1210/jc.2005-2838 1:CAS:528: DC%2BD28XosFGhs70%3D 16684830 (Pubitemid 44271732)
17. MJ Schlumberger 1998 Papillary and follicular thyroid carcinoma N Engl J Med 338 297 306 10.1056/NEJM199801293380506 1:STN:280:DyaK1c%2Fpt1SktA%3D%3D 9445411 (Pubitemid 28065257)
18. LF de Geus-Oei HY Oei G Hennemann EP Krenning 2002 Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer Eur J Nucl Med Mol Imaging 29 768 774 10.1007/s00259-002-0781-x 12029550
19. SR Hinds 2nd AL Stack DJ Stocker 2008 Low-iodine diet revisited: importance in nuclear medicine imaging and management Clin Nucl Med 33 247 250 10.1097/RLU.0b013e3181662f9e 18356660
20. R Sanchez AL Espinosa de los Monteros V Mendoza E Brea I Hernandez E Sosa, et al. 2002 Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma Arch Med Res 33 478 481 10.1016/S0188-4409(02)00394-6 1:CAS:528:DC%2BD38XovFGht78%3D 12459319 (Pubitemid 35397264)
21. GS Anderson S Fish K Nakhoda H Zhuang A Alavi SJ Mandel 2003 Comparison of I-123 and I-131 for whole-body imaging after stimulation by recombinant human thyrotropin: a preliminary report Clin Nucl Med 28 93 96 10.1097/00003072- 200302000-00001 12544124 (Pubitemid 38281999)
22. W Yan PJ Roach GJ Bautovich DL Learoyd BG Robinson 2007 Timing of iodine-123 scintigraphy following use of recombinant human thyrotropin in differentiated thyroid carcinoma Clin Nucl Med 32 375 377 10.1097/01.rlu. 0000259616.75495.b8 17452866 (Pubitemid 46659172)